Transplant; Complication, Failure Clinical Trial
— RDNOfficial title:
Retroperitoneoscopic Donor Nephrectomy: a Retrospective Single-center Study
Verified date | October 2019 |
Source | Samsun Liv Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
to compare the results of right and left-sided retroperitoneoscopic donor nephrectomy (RDN).
Status | Completed |
Enrollment | 158 |
Est. completion date | July 22, 2019 |
Est. primary completion date | May 8, 2019 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 57 Years |
Eligibility |
Inclusion Criteria: - Adult donors - Kidney donors undergoing retroperitoneoscopic donor nephrectomy - Recipients of the kidneys - Donors with the consent form - Recipients with consent form Exclusion Criteria: - open donor nephrectomies - donors without the consent form - Recipients without the consent form |
Country | Name | City | State |
---|---|---|---|
Turkey | Ondokuz Mayis University | Samsun | |
Turkey | Samsun Liv Hospital | Samsun |
Lead Sponsor | Collaborator |
---|---|
Samsun Liv Hospital | Ondokuz Mayis University |
Turkey,
Hsu JW, Reese PP, Naji A, Levine MH, Abt PL. Increased early graft failure in right-sided living donor nephrectomy. Transplantation. 2011 Jan 15;91(1):108-14. doi: 10.1097/TP.0b013e3181fd0179. — View Citation
Kumar A, Chaturvedi S, Gulia A, Maheshwari R, Dassi V, Desai P. Laparoscopic Live Donor Nephrectomy: Comparison of Outcomes Right Versus Left. Transplant Proc. 2018 Oct;50(8):2327-2332. doi: 10.1016/j.transproceed.2018.03.034. Epub 2018 Mar 16. — View Citation
Ratner LE, Ciseck LJ, Moore RG, Cigarroa FG, Kaufman HS, Kavoussi LR. Laparoscopic live donor nephrectomy. Transplantation. 1995 Nov 15;60(9):1047-9. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Operation time | time from onset to complete of surgery | at the end of the surgery | |
Primary | Blood loss | amount of bleeding during surgery (mililiter) | at the end of the surgery | |
Primary | warm ishemia time | time from renal artery and vein dissection of the kidney to the initiation of perfusion on the bench table. | at the end of the surgery | |
Primary | Intraoperative complications | abnormal problems that may be seen during surgery and require additional intervention. | at the end of the surgery | |
Primary | incisional hernia | abdominal incision or trocar site defects of donors | up to 2 years | |
Primary | postoperative complication | abnormal problems that may be seen after surgery and require additional intervention or follow-up (grade I-V) | up to 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04848844 -
The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
|
||
Recruiting |
NCT05050513 -
Evaluation of HEMO2Life® for Kidney Graft Preservation (OXYOP): 4 Years Follow-up
|
||
Not yet recruiting |
NCT05469906 -
Evaluation at 5 and 10 Years of Renal Transplant Patients
|